|4Feb 8, 5:29 PM ET

Gabay Avraham 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Feb 8, 2021

Insider Transaction Report

Form 4
Period: 2021-02-03
Gabay Avraham
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-03+40,00040,000 total
    Exercise: $10.40Exp: 2031-02-03Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The Stock Option will vest in 4 equal installments as follows: 10,000 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary